AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365 | +2.2% | 5,229 | +5.2% | 0.00% | 0.0% |
| Q2 2023 | $357 | +28.0% | 4,972 | +9.8% | 0.00% | +50.0% |
| Q1 2023 | $279 | -31.4% | 4,529 | -14.2% | 0.00% | -50.0% |
| Q4 2022 | $407 | -99.8% | 5,279 | +9.7% | 0.00% | +100.0% |
| Q3 2022 | $215,000 | +23.6% | 4,812 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $174,000 | -7.0% | 4,551 | +0.6% | 0.00% | +100.0% |
| Q1 2022 | $187,000 | -47.2% | 4,525 | -13.8% | 0.00% | -66.7% |
| Q2 2021 | $354,000 | +58.7% | 5,248 | +33.2% | 0.00% | -62.5% |
| Q1 2021 | $223,000 | -36.8% | 3,940 | -9.0% | 0.01% | -38.5% |
| Q4 2020 | $353,000 | +15.0% | 4,332 | +0.5% | 0.01% | 0.0% |
| Q3 2020 | $307,000 | -15.9% | 4,310 | -2.8% | 0.01% | -23.5% |
| Q2 2020 | $365,000 | +33.7% | 4,433 | -4.4% | 0.02% | +142.9% |
| Q1 2020 | $273,000 | -42.4% | 4,635 | +1.0% | 0.01% | -22.2% |
| Q4 2019 | $474,000 | – | 4,588 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |